Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.

Saved in:
Bibliographic Details
Title: Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Authors: Vermij L; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Jobsen JJ; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands., León-Castillo A; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Brinkhuis M; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., Roothaan S; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., Powell ME; Department of Clinical Oncology, Barts and The London NHS Trust, London, UK., de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Khaw P; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Mileshkin LR; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Fyles A; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Genestie C; Department of Pathology, Gustave Roussy, Villejuif, France., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Crosbie EJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, UK.; Department of Obstetrics and Gynaecology, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Mackay HJ; Department of Medical Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Nijman HW; Department of Gynaecology, University Medical Center Groningen, Groningen, The Netherlands., Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. T.Bosse@lumc.nl.
Corporate Authors: TransPORTEC Consortium
Source: British journal of cancer [Br J Cancer] 2023 Mar; Vol. 128 (7), pp. 1360-1368. Date of Electronic Publication: 2023 Jan 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-023-02141-0